Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ANTIBODIES, MONOCLONAL, HUMANIZED - THERAPEUTIC USE , . Treffer: 37

2022

Badi, YE; Pavel, AB; Pavlidis, S; Riley, JH; Bates, S; Kermani, NZ; Knowles, R; Kolmert, J; Wheelock, CE; Worsley, S; Uddin, M; Alving, K; Bakke, PS; Behndig, A; Caruso, M; Chanez, P; Fleming, LJ; Fowler, SJ; Frey, U; Howarth, P; Horváth, I; Krug, N; Maitland-van, der, Zee, AH; Montuschi, P; Roberts, G; Sanak, M; Shaw, DE; Singer, F; Sterk, PJ; Djukanovic, R; Dahlen, SE; Guo, YK; Chung, KF; Guttman-Yassky, E; Adcock, IM, , U-BIOPRED, Study, Group Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
J Allergy Clin Immunol. 2022; 149(1):89-101 Doi: 10.1016/j.jaci.2021.04.010
Web of Science PubMed FullText FullText_MUG

 

Hatzl, S; Krause, R; Schilcher, G Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022; 386(15): 1480 Doi: 10.1056/NEJMc2201606
Web of Science PubMed FullText FullText_MUG

 

2021

Canzian, A; Venhoff, N; Urban, ML; Sartorelli, S; Ruppert, AM; Groh, M; Girszyn, N; Taillé, C; Maurier, F; Cottin, V; de, Moreuil, C; Germain, V; Samson, M; Jachiet, M; Denis, L; Rieu, V; Smets, P; Pugnet, G; Deroux, A; Durel, CA; Aouba, A; Cathébras, P; Deligny, C; Faguer, S; Gil, H; Godeau, B; Lifermann, F; Phin-Huynh, S; Ruivard, M; Bonniaud, P; Puéchal, X; Kahn, JE; Thiel, J; Dagna, L; Guillevin, L; Vaglio, A; Emmi, G; Terrier, B, , French, Vasculitis, Study, Group, and, the, European, EGPA, Study, Group Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
Arthritis Rheumatol. 2021; 73(3): 498-503. Doi: 10.1002/art.41534
Web of Science PubMed FullText FullText_MUG

 

2020

Buttgereit, F; Matteson, EL; Dejaco, C Polymyalgia Rheumatica and Giant Cell Arteritis.
JAMA. 2020; 324(10):993-994 Doi: 10.1001/jama.2020.10155
Web of Science PubMed FullText FullText_MUG

 

Camellino, D; Matteson, EL; Buttgereit, F; Dejaco, C Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
Nat Rev Rheumatol. 2020; 16(9):481-495 Doi: 10.1038/s41584-020-0458-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Füreder, W; Sperr, WR; Heibl, S; Zebisch, A; Pfeilstöcker, M; Stefanzl, G; Jäger, E; Greiner, G; Schwarzinger, I; Kundi, M; Keil, F; Hoermann, G; Bettelheim, P; Valent, P Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
Ann Hematol. 2020; 99(10):2303-2313 Doi: 10.1007/s00277-020-04214-z
Web of Science PubMed FullText FullText_MUG

 

Ständer, S; Yosipovitch, G; Legat, FJ; Lacour, JP; Paul, C; Narbutt, J; Bieber, T; Misery, L; Wollenberg, A; Reich, A; Ahmad, F; Piketty, C Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
N Engl J Med. 2020; 382(8): 706-716. Doi: 10.1056/NEJMoa1908316 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Criner, GJ; Celli, BR; Brightling, CE; Agusti, A; Papi, A; Singh, D; Sin, DD; Vogelmeier, CF; Sciurba, FC; Bafadhel, M; Backer, V; Kato, M; Ramírez-Venegas, A; Wei, YF; Bjermer, L; Shih, VH; Jison, M; O'Quinn, S; Makulova, N; Newbold, P; Goldman, M; Martin, UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators Benralizumab for the Prevention of COPD Exacerbations.
N Engl J Med. 2019; 381(11):1023-1034 Doi: 10.1056/NEJMoa1905248
Web of Science PubMed FullText FullText_MUG

 

Zalaudek, I; Corneli, P; Vernoni, S; Fedele, D; Papa, G; Conforti, C; Retrosi, C; Vezzoni, R; Fagotti, S; Longone, M; Farinazzo, E; di, Meo, N; Pizzichetta, MA Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
Dermatol Ther. 2019; 32(6): e13107 Doi: 10.1111/dth.13107 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2018

Gandhi, L; Rodríguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SY; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC; KEYNOTE-189 Investigators Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018; 378(22): 2078-2092. Doi: 10.1056/NEJMoa1801005
Web of Science PubMed FullText FullText_MUG

 

Moog, P; Jost, PJ; Büttner-Herold, M Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.
BMC Nephrol. 2018; 19(1):106-106 Doi: 10.1186/s12882-018-0904-7 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148 Doi: 10.1016/j.ejca.2017.11.008 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Dejaco, C; Brouwer, E; Mason, JC; Buttgereit, F; Matteson, EL; Dasgupta, B Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.
NAT REV RHEUMATOL. 2017; 13(10): 578-592. Doi: 10.1038/nrrheum.2017.142 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, JJ; Nathan, P; Dummer, R; Forsea, AM; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Kukushkina, M; De La Cruz Merino, L; Ymeri, A; Risteski, M; Garbe, C More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer. 2017; 75(4):313-322 Doi: 10.1016/j.ejca.2017.01.012
Web of Science PubMed FullText FullText_MUG

 

Petrella, TM; Robert, C; Richtig, E; Miller, WH; Masucci, GV; Walpole, E; Lebbe, C; Steven, N; Middleton, MR; Hille, D; Zhou, W; Ibrahim, N; Cebon, J Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
EUR J CANCER. 2017; 86(5): 115-124. Doi: 10.1016/j.ejca.2017.08.032 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281 Doi: 10.1007/s00404-015-3879-7
Web of Science PubMed FullText FullText_MUG

 

2015

Bykerk, VP; Östör, AJ; Alvaro-Gracia, J; Pavelka, K; Román Ivorra, JA; Graninger, W; Bensen, W; Nurmohamed, MT; Krause, A; Bernasconi, C; Aassi, M; Sibilia, J Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
Clin Rheumatol. 2015; 34(3):563-571 Doi: 10.1007/s10067-014-2857-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; all ABCSG-18 investigators Denosumab and fracture risk in women with breast cancer - Author's reply.
Lancet. 2015; 386(10008): 2057-2058. Doi: 10.1016/S0140-6736(15)00975-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443. Doi: 10.1016/S0140-6736(15)60995-3
Web of Science PubMed FullText FullText_MUG

 

Kreutzer, TC; Wolf, A; Dirisamer, M; Strauss, RW; Foerster, P; Feltgen, N; Pielen, A; Hattenbach, LO; Kampik, A; Priglinger, SG Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.
Ophthalmologica. 2015; 233(1):8-17 Doi: 10.1159/000369566 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 Doi: 10.1056/NEJMoa1503093 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Heiduschka, G; Grah, A; Oberndorfer, F; Seemann, R; Kranz, A; Kornek, G; Wrba, F; Thurnher, D; Selzer, E Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
Strahlenther Onkol. 2014; 190(9):832-838 Doi: 10.1007/s00066-014-0652-y
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37 Doi: 10.1007/s10006-012-0376-z
PubMed FullText FullText_MUG

 

Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54 Doi: 10.1016/j.bone.2013.10.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 Doi: 10.1158/1078-0432.CCR-13-1440 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tarmann, L; Langmann, G; Mayer, C; Weger, M; Haas, A; Wackernagel, W Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Acta Ophthalmol. 2014; 92(8):e694-e696 Doi: 10.1111/aos.12424 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Krebs, I; Vécsei Marlovits, V; Bodenstorfer, J; Glittenberg, C; Ansari Shahrezaei, S; Ristl, R; Binder, S Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Acta Ophthalmol. 2013; 91(3):e178-e183 Doi: 10.1111/aos.12018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kump, PK; Högenauer, C; Wenzl, HH; Petritsch, W A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
J Crohns Colitis. 2013; 7(1):e15-e18 Doi: 10.1016/j.crohns.2012.04.015 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203 Doi: 10.1097/CAD.0b013e32835b9589
Web of Science PubMed FullText FullText_MUG

 

Resch, B; Michel-Behnke, I Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab.
Curr Opin Cardiol. 2013; 28(2):85-91 Doi: 10.1097/HCO.0b013e32835dce2f
Web of Science PubMed FullText FullText_MUG

 

Seidel, G; Werner, C; Weger, M; Steinbrugger, I; Haas, A Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Acta Ophthalmol. 2013; 91(6):e482-e485 Doi: 10.1111/aos.12111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Boltz, A; Ruiâ, M; Jonas, JB; Tao, Y; Rensch, F; Weger, M; Garhöfer, G; Frantal, S; El-Shabrawi, Y; Schmetterer, L Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.
Ophthalmology. 2012; 119(8):1615-1620 Doi: 10.1016/j.ophtha.2012.02.001
Web of Science PubMed FullText FullText_MUG

 

Grunewald, TGP; Greulich, N; Kontny, U; Fruhwald, M; Rutkowski, S; Kordes, U; Scheurlen, W; Schmidt, W; Stachel, D; Metzler, M; Mittler, U; Graf, N; Benesch, M; Burdach, S Targeted Therapeutics in Treatment of Children and Young Adults with Solid Tumors: an Expert Survey and Review of the Literature
Klin Padiatr. 2012; 224(3):124-131 Doi: 10.1055/s-0032-1301930
Web of Science PubMed FullText FullText_MUG

 

Manzoni, P; Paes, B; Resch, B; Mejias, A; Ramilo, O; Carbonell-Estrany, X; Bont, L High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.
Early Hum Dev. 2012; 88 Suppl 2(8):S34-S41 Doi: 10.1016/S0378-3782(12)70012-9
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Geist, C; Dahlbom, M; Silverman, DH; Satyamurthy, N; Phelps, ME; Chen, W 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
J Nucl Med. 2012; 53(1):29-36 Doi: 10.2967/jnumed.111.092387 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Thonhofer, R; Hiller, M; Just, H; Trummer, M; Siegel, C; Dejaco, C Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
Rheumatol Int. 2011; 31(12): 1653-1656. Doi: 10.1007/s00296-010-1631-y (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum